“showed a trend”

FDG SUV mean uptake at day 3 correlated with tumor growth day 10 (r 2 = 0.45; P = 0.034) and showed a trend towards correlation with day 7 (r 2 = 0.38; P = 0.057).

The latency to NREM sleep onset also showed a trend toward an increase (133.0 ± 36.8 min in mutants vs. 38.9 ± 16.3 min in controls, p = 0.057, Figure 4 B).

Again, parameters for the high and low forgetters differed significantly (t (16) = 1.77, p < 0.05, one-tailed), and they showed a trend for a negative influence of DLPFC on HC activation in the high forgetters only (high forgetters: t (8) = −1.77, p = 0.057, one-tailed; low forgetters: t (8) = 1.03, p = 0.334).

placebo in 402 patients at high-risk for fatal ventricular arrhythmias showed a trend toward a reduction of the primary endpoint (risk reduction of −28% of the time to the first ICD event for VT or VF, or death from any cause; P = 0.057).

ITD + CR patients showed a trend towards lower frequencies of terminal myeloid DCs (mDC1, p = 0.057; mDC2, p = 0.0912) in comparison to HD (Fig. 3b ).

Male B6.Del16 +/ Bdh1-Tfrc mice showed a trend towards increased latency that did not reach significance (main effect of genotype, F 1, 28 = 3.922, p = 0.057), swam a greater distance (main effect of genotype, F 1, 28 = 4.621, p < 0.05), but had similar swim speed (main effect of genotype, F 1, 28 = 0.493, p > 0.05) to reach the hidden platform on day 5 compared with B6.WT littermates (Supplemental Fig. 5d–f ).

2c ) but showed a trend for larger litters compared with native backcrosses (native x immigrant F1-F4 pairs; t = 1.9, p = 0.057, 95% CI [−0.18, 2.02]; Fig. 2c ) although not statistically significant.

Subsequent univariate ANOVAs revealed that MA-dependent participants exhibited an increase in total object interactions [ F (1,32) = 11.8, p < 0.01], time spent with objects [ F (1,32) = 11.0, p < 0.01], percent perseverative interactions [ F (1,32) = 15.9, p < 0.001], and showed a trend towards elevated object-proximal sector entries [ F (1,32) = 3.8, p = 0.057] compared to the drug-free comparison group as illustrated in Fig. 1 .

Anthropometrical and physiological characteristics were not different at baseline (CID1) and post-weight loss (CID2), and only showed a trend (p = 0.057) for younger age in the weight-losers compared to the -regainers ( Table 2 ).

Nonetheless, they showed a trend for a higher frequency of DRB1*01:01 (0.182 vs. 0.064, p = 0.057), DQA1*01:01 (0.227 vs. 0.108, p = 0.091) and DQB1*06:04 (0.091 vs. 0.015, p = 0.055).

In the competing risks analysis, diabetes mellitus showed a trend towards a lower risk of BSI development that did not reach statistical significance (subdistribution hazard ratio (SHR): 0.334; 95% CI: 0.108–1.040; p = 0.057), consistent in direction with the logistic regression findings ( Table 5 ). 3.3.

The use of the median vein also showed a trend toward increased risk (OR = 1.84; P = 0.057), although this finding did not reach statistical significance.

Risperidone-OS showed a trend toward a lower hazard relative to asenapine-SL (hazard ratio 0.59; 95% CI: 0.34–1.02; P = 0.057).

on Caucasians from the Portuguese population showed a trend toward increased risk of thyroid cancer for people who are homozygous for the RAD51 rs180132 polymorphic allele variant (adjusted OR = 1.9; 95% CI = 1.0–3.5; p = 0.057) [ 44 ].

The meta-analysis based on 18 comparisons showed a trend ( p = 0.057) toward increased final body weight (FBW) in lambs receiving malic acid supplementation.

Stride length showed a trend toward improvement (p = 0.057, +5.43%, 95% CI [−0.2, 11.1]).

The ROC curve analysis for endoscopic response in the sigmoid demonstrated a significant AUROC for RSE [0.763 (0.61–0.92), P = .003], while FCP only showed a trend [0.677 (0.51–0.84), P = .057; Figure S5 ].

Post hoc tests showed that only JuvCond-Ext animals showed a trend toward reduced activation of the caudal CeA with extinction ( P = 0.057; Supplemental Fig.

Telmisartan treatment showed a trend toward increasing the urine adenosine to urine creatinine ratio ( P = 0.057, Fig. 3 A ).

However, compared to the former, the latter group showed a trend toward lower hBD-2 levels (2152.5 ± 1251.6 vs. 1716.9 ± 1248.6 pg/mL, respectively; p = 0.057; Fig. 1 A).

Compared to group B, group A showed a trend toward lower rates of structural heart disease predisposition (48.3% vs. 64.1%, p = 0.057) and for undergoing elective medical procedures in the previous 3 months (10% vs. 23.9%, p = 0.08).

Interaction between GROUP and GVS was not significant (p = 0.674), neither was GROUP × VS ( p = 0.75), the three-way interaction GROUP × GVS × VS showed a trend ( F (6, 312) = 2.06, p = 0.057, η 2 = 0.008, Fig. 5 B).

Moreover, the LC group showed a trend toward a decrease in leukocyte number (white blood cell; P = 0.057).

High IL7R expression showed a trend toward poor prognosis ( P = .057), whereas high CD8A expression was a protective factor ( P = .02).

Clinical results At day two following treatment, ketamine significantly improved MADRS scores (mean difference -6.5 [95% CI -10.6 to -2.5]; paired t -test, p = 0.003), TEPS-anticipatory scores (mean difference 6.8 [95% CI 2.9 to 9.5]; paired t -test, p = 0.038), TEPS-consummatory scores (mean difference 5.6 [95% CI 1.8 to 6.1]; paired t -test, p = 0.018) and showed a trend to improve SHAPS scores (mean difference -5.2 [95% CI -10.7 to 0.2]; paired t -test, p = 0.057) compared to placebo (Supplementary Fig.